Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Algernon Pharmaceuticalsinc (AGN.CN)

Algernon Pharmaceuticalsinc (AGN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000 GlobeNewswire - Mon Jun 30, 4:29PM CDT

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon Announces $1M Private Placement GlobeNewswire - Tue May 27, 6:00AM CDT

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition GlobeNewswire - Thu May 22, 7:50PM CDT

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer’s Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology GlobeNewswire - Tue May 13, 6:00AM CDT

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon Announces Warrant Extension GlobeNewswire - Mon May 5, 6:47AM CDT

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease GlobeNewswire - Tue Apr 8, 6:00AM CDT

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon NeuroScience Engages Netcapital Securities for Planned Regulation A Financing GlobeNewswire - Thu Mar 6, 6:00AM CST

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. Sándor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study GlobeNewswire - Tue Feb 11, 6:00AM CST

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity Investment GlobeNewswire - Wed Feb 5, 6:00AM CST

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)
Algernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent GlobeNewswire - Mon Jan 6, 6:00AM CST

AGN.CN : 0.0650 (unch)
AGNPF : 0.0390 (-1.76%)

Barchart Exclusives

Retirement Ready: 3 Dividend Stocks to Set and Forget Barchart - Tue Jul 15, 6:30PM CDT
These are three rock-solid dividend stocks you can buy now and confidently forget, knowing they’ll keep working for you year after year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot